A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Clinical trial NCT05816382 · RECRUITING

Trial details

NCT number: NCT05816382
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2023-04-05
Primary completion: 2028-02-28
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.